Tagomics
Tagomics is a precision medicine company developing LiquiPath™, a platform for non-invasive, multi-organ drug safety monitoring from a single blood sample.
LiquiPath uses next-generation cell-free DNA technology to detect and monitor tissue injury across organs and species, supporting drug safety assessment from preclinical development through clinical trials and on-market use.
By enabling earlier detection of treatment-related toxicities, LiquiPath could support more informed safety decisions. For ADC developers, it offers a new approach to understanding and monitoring treatment-related toxicity.
